Autologous Dendritic Cells Prolong Allograft Survival Through Tmem176b‐Dependent Antigen Cross‐Presentation. Issue 5 (14th April 2014)

• Record Type: Journal Article
• Authors: Segovia, M.; Louvet, C.; Charnet, P.; Savina, A.; Tilly, G.; Gautreau, L.; Carretero‐Iglesia, L.; Beriou, G.; Cebrian, I.; Cens, T.; Hepburn, L.; Chiffoleau, E.; Floto, R. A.; Anegon, I.; Amigorena, S.; Hill, M.; Cuturi, M. C.
• Is Part Of: American journal of transplantation. Volume 14:Issue 5(2014:May)
• Page Start: 1021
• Page End: 1031
• Publication Date: 2014-04-14
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; 617.95
• DOI: 10.1111/ajt.12708
• Languages: English
• ISSNs: 1600-6135

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ajt12708-sec-0001" sec-type="section"> <p>The administration of autologous (recipient‐derived) tolerogenic dendritic cells (ATDCs) is under clinical evaluation. However, the molecular mechanisms by which these cells prolong graft survival in a donor‐specific manner is unknown. Here, we tested mouse ATDCs for their therapeutic potential in a skin transplantation model. ATDC injection in combination with anti‐CD3 treatment induced the accumulation of CD8<sup>+</sup>CD11c<sup>+</sup> T cells and significantly prolonged allograft survival. TMEM176B is an intracellular protein expressed in ATDCs and initially identified in allograft tolerance. We show that <italic>Tmem176b</italic><sup>−/−</sup> ATDCs completely failed to trigger both phenomena but recovered their effect when loaded with donor peptides before injection. These results strongly suggested that ATDCs require TMEM176B to cross‐present antigens in a tolerogenic fashion. In agreement with this, <italic>Tmem176b</italic><sup>−/−</sup> ATDCs specifically failed to cross‐present male antigens or ovalbumin to CD8<sup>+</sup> T cells. Finally, we observed that a <italic>Tmem176b</italic>‐dependent cation current controls phagosomal pH, a critical parameter in cross‐presentation. Thus, ATDCs require TMEM176B to cross‐present donor antigens to induce donor‐specific CD8<sup>+</sup>CD11c<sup>+</sup> T cells with regulatory properties and prolong graft survival.</p> </sec> </abstract>